Adaptive pathways: Why are we cautious?
![](https://www.aim-mutual.org/wp-content/uploads/2017/04/medecine.jpg)
In order to improve access to medicines, the European Medicines Agency (EMA) has recently been merrily pushing towards speeding up marketing authorisation for new medicines. Several projects have been launched: GetReal, ADAPTSMART